Research ExplorerPublicationsAssociations of frailty with health care costs - results of ...

Associations of frailty with health care costs - results of the ESTHER cohort study

Standard

Associations of frailty with health care costs - results of the ESTHER cohort study. / Bock, Jens-Oliver; König, Hans-Helmut; Brenner, Hermann; Haefeli, Walter E; Quinzler, Renate; Matschinger, Herbert; Saum, Kai-Uwe; Schöttker, Ben; Heider, Dirk.

In: BMC HEALTH SERV RES, Vol. 16, No. 1, 2016, p. 128.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Bock, J-O, König, H-H, Brenner, H, Haefeli, WE, Quinzler, R, Matschinger, H, Saum, K-U, Schöttker, B & Heider, D 2016, 'Associations of frailty with health care costs - results of the ESTHER cohort study', BMC HEALTH SERV RES, vol. 16, no. 1, pp. 128. https://doi.org/10.1186/s12913-016-1360-3

APA

Bock, J-O., König, H-H., Brenner, H., Haefeli, W. E., Quinzler, R., Matschinger, H., Saum, K-U., Schöttker, B., & Heider, D. (2016). Associations of frailty with health care costs - results of the ESTHER cohort study. BMC HEALTH SERV RES, 16(1), 128. https://doi.org/10.1186/s12913-016-1360-3

Vancouver

Bock J-O, König H-H, Brenner H, Haefeli WE, Quinzler R, Matschinger H et al. Associations of frailty with health care costs - results of the ESTHER cohort study. BMC HEALTH SERV RES. 2016;16(1):128. https://doi.org/10.1186/s12913-016-1360-3

Bibtex

@article{605e82a2e6a74e578e88970597395a7d,
title = "Associations of frailty with health care costs - results of the ESTHER cohort study",
abstract = "BACKGROUND: The concept of frailty is rapidly gaining attention as an independent syndrome with high prevalence in older adults. Thereby, frailty is often related to certain adverse outcomes like mortality or disability. Another adverse outcome discussed is increased health care utilization. However, only few studies examined the impact of frailty on health care utilization and corresponding costs. The aim of this study was therefore to investigate comprehensively the relationship between frailty, health care utilization and costs.METHODS: Cross sectional data from 2598 older participants (57-84 years) recruited in the Saarland, Germany, between 2008 and 2010 was used. Participants passed geriatric assessments that included Fried's five frailty criteria: weakness, slowness, exhaustion, unintentional weight loss, and physical inactivity. Health care utilization was recorded in the sectors of inpatient treatment, outpatient treatment, pharmaceuticals, and nursing care.RESULTS: Prevalence of frailty (≥3 symptoms) was 8.0 %. Mean total 3-month costs of frail participants were €3659 (4 or 5 symptoms) and €1616 (3 symptoms) as compared to €642 of nonfrail participants (no symptom). Controlling for comorbidity and general socio-demographic characteristics in multiple regression models, the difference in total costs between frail and non-frail participants still amounted to €1917; p < .05 (4 or 5 symptoms) and €680; p < .05 (3 symptoms). Among the 5 symptoms of frailty, weight loss and exhaustion were significantly associated with total costs after controlling for comorbidity.CONCLUSIONS: The study provides evidence that frailty is associated with increased health care costs. The analyses furthermore indicate that frailty is an important factor for health care costs independent from pure age and comorbidity. Costs were rather attributable to frailty (and comorbidity) than to age. This stresses that the overlapping concepts of multimorbidity and frailty are both necessary to explain health care use and corresponding costs among older adults.",
author = "Jens-Oliver Bock and Hans-Helmut K{\"o}nig and Hermann Brenner and Haefeli, {Walter E} and Renate Quinzler and Herbert Matschinger and Kai-Uwe Saum and Ben Sch{\"o}ttker and Dirk Heider",
year = "2016",
doi = "10.1186/s12913-016-1360-3",
language = "English",
volume = "16",
pages = "128",
journal = "BMC HEALTH SERV RES",
issn = "1472-6963",
publisher = "BioMed Central Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - Associations of frailty with health care costs - results of the ESTHER cohort study

AU - Bock, Jens-Oliver

AU - König, Hans-Helmut

AU - Brenner, Hermann

AU - Haefeli, Walter E

AU - Quinzler, Renate

AU - Matschinger, Herbert

AU - Saum, Kai-Uwe

AU - Schöttker, Ben

AU - Heider, Dirk

PY - 2016

Y1 - 2016

N2 - BACKGROUND: The concept of frailty is rapidly gaining attention as an independent syndrome with high prevalence in older adults. Thereby, frailty is often related to certain adverse outcomes like mortality or disability. Another adverse outcome discussed is increased health care utilization. However, only few studies examined the impact of frailty on health care utilization and corresponding costs. The aim of this study was therefore to investigate comprehensively the relationship between frailty, health care utilization and costs.METHODS: Cross sectional data from 2598 older participants (57-84 years) recruited in the Saarland, Germany, between 2008 and 2010 was used. Participants passed geriatric assessments that included Fried's five frailty criteria: weakness, slowness, exhaustion, unintentional weight loss, and physical inactivity. Health care utilization was recorded in the sectors of inpatient treatment, outpatient treatment, pharmaceuticals, and nursing care.RESULTS: Prevalence of frailty (≥3 symptoms) was 8.0 %. Mean total 3-month costs of frail participants were €3659 (4 or 5 symptoms) and €1616 (3 symptoms) as compared to €642 of nonfrail participants (no symptom). Controlling for comorbidity and general socio-demographic characteristics in multiple regression models, the difference in total costs between frail and non-frail participants still amounted to €1917; p < .05 (4 or 5 symptoms) and €680; p < .05 (3 symptoms). Among the 5 symptoms of frailty, weight loss and exhaustion were significantly associated with total costs after controlling for comorbidity.CONCLUSIONS: The study provides evidence that frailty is associated with increased health care costs. The analyses furthermore indicate that frailty is an important factor for health care costs independent from pure age and comorbidity. Costs were rather attributable to frailty (and comorbidity) than to age. This stresses that the overlapping concepts of multimorbidity and frailty are both necessary to explain health care use and corresponding costs among older adults.

AB - BACKGROUND: The concept of frailty is rapidly gaining attention as an independent syndrome with high prevalence in older adults. Thereby, frailty is often related to certain adverse outcomes like mortality or disability. Another adverse outcome discussed is increased health care utilization. However, only few studies examined the impact of frailty on health care utilization and corresponding costs. The aim of this study was therefore to investigate comprehensively the relationship between frailty, health care utilization and costs.METHODS: Cross sectional data from 2598 older participants (57-84 years) recruited in the Saarland, Germany, between 2008 and 2010 was used. Participants passed geriatric assessments that included Fried's five frailty criteria: weakness, slowness, exhaustion, unintentional weight loss, and physical inactivity. Health care utilization was recorded in the sectors of inpatient treatment, outpatient treatment, pharmaceuticals, and nursing care.RESULTS: Prevalence of frailty (≥3 symptoms) was 8.0 %. Mean total 3-month costs of frail participants were €3659 (4 or 5 symptoms) and €1616 (3 symptoms) as compared to €642 of nonfrail participants (no symptom). Controlling for comorbidity and general socio-demographic characteristics in multiple regression models, the difference in total costs between frail and non-frail participants still amounted to €1917; p < .05 (4 or 5 symptoms) and €680; p < .05 (3 symptoms). Among the 5 symptoms of frailty, weight loss and exhaustion were significantly associated with total costs after controlling for comorbidity.CONCLUSIONS: The study provides evidence that frailty is associated with increased health care costs. The analyses furthermore indicate that frailty is an important factor for health care costs independent from pure age and comorbidity. Costs were rather attributable to frailty (and comorbidity) than to age. This stresses that the overlapping concepts of multimorbidity and frailty are both necessary to explain health care use and corresponding costs among older adults.

U2 - 10.1186/s12913-016-1360-3

DO - 10.1186/s12913-016-1360-3

M3 - SCORING: Journal article

C2 - 27074800

VL - 16

SP - 128

JO - BMC HEALTH SERV RES

JF - BMC HEALTH SERV RES

SN - 1472-6963

IS - 1

ER -